In vivo targeting of HER2-positive tumor using 2-helix affibody molecules
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In vivo targeting of HER2-positive tumor using 2-helix affibody molecules
Authors
Keywords
-
Journal
AMINO ACIDS
Volume 43, Issue 1, Pages 405-413
Publisher
Springer Nature
Online
2011-10-08
DOI
10.1007/s00726-011-1096-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel 18F-labeled two-helix scaffold protein for PET imaging of HER2-positive tumor
- (2011) Zheng Miao et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
- (2010) Jan Terje Andersen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Engineered Two-Helix Small Proteins for Molecular Recognition
- (2009) Jack M. Webster et al. CHEMBIOCHEM
- Monitoring therapeutic response of human ovarian cancer to 17-DMAG by noninvasive PET imaging with 64Cu-DOTA-trastuzumab
- (2009) Gang Niu et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- A 2-Helix Small Protein Labeled with 68Ga for PET Imaging of HER2 Expression
- (2009) G. Ren et al. JOURNAL OF NUCLEAR MEDICINE
- Micro-SPECT/CT with 111In-DTPA-Pertuzumab Sensitively Detects Trastuzumab-Mediated HER2 Downregulation and Tumor Response in Athymic Mice Bearing MDA-MB-361 Human Breast Cancer Xenografts
- (2009) K. McLarty et al. JOURNAL OF NUCLEAR MEDICINE
- Affibody Molecules for Epidermal Growth Factor Receptor Targeting In Vivo: Aspects of Dimerization and Labeling Chemistry
- (2009) V. Tolmachev et al. JOURNAL OF NUCLEAR MEDICINE
- Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
- (2009) E. C.F. Dijkers et al. JOURNAL OF NUCLEAR MEDICINE
- Changes in HER2 Expression in Breast Cancer Xenografts After Therapy Can Be Quantified Using PET and 18F-Labeled Affibody Molecules
- (2009) G. Kramer-Marek et al. JOURNAL OF NUCLEAR MEDICINE
- Targeting of HER2-Expressing Tumors with a Site-Specifically 99mTc-Labeled Recombinant Affibody Molecule, ZHER2:2395, with C-Terminally Engineered Cysteine
- (2009) S. Ahlgren et al. JOURNAL OF NUCLEAR MEDICINE
- On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
- (2009) A. Orlova et al. JOURNAL OF NUCLEAR MEDICINE
- Evaluation of the Radiocobalt-Labeled [MMA-DOTA-Cys61]-ZHER2:2395-Cys Affibody Molecule for Targeting of HER2-Expressing Tumors
- (2009) Helena Wållberg et al. MOLECULAR IMAGING AND BIOLOGY
- Automated radiolabelling of monoclonal antibodies with the Modular Lab system
- (2009) David Ellison et al. NUCLEAR MEDICINE COMMUNICATIONS
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Slow Internalization of Anti-HER2 Synthetic Affibody Monomer 111In-DOTA-ZHER2:342-pep2 : Implications for Development of Labeled Tracers
- (2008) Helena Wållberg et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Imaging of HER-2 Overexpression in Tumors for Guiding Therapy
- (2008) V. Tolmachev CURRENT PHARMACEUTICAL DESIGN
- Development and preclinical characterisation of 99mTc-labelled Affibody molecules with reduced renal uptake
- (2008) Torun Ekblad et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Alternative binding proteins: Affibody binding proteins developed from a small three-helix bundle scaffold
- (2008) Per-Åke Nygren FEBS Journal
- Small-Animal PET Imaging of Human Epidermal Growth Factor Receptor Type 2 Expression with Site-Specific 18F-Labeled Protein Scaffold Molecules
- (2008) Z. Cheng et al. JOURNAL OF NUCLEAR MEDICINE
- EGFR Antagonists in Cancer Treatment
- (2008) Fortunato Ciardiello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Integrating trastuzumab in the neoadjuvant treatment of primary breast cancer: Accumulating evidence of efficacy, synergy and safety
- (2007) George Lazaridis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More